Benefit Risk Medical Assessor

We are currently looking for a Benefit Risk Medical Assessor to join our Benefit-Risk Evaluation I Function within the Safety and Surveillance group.

The Benefit Risk groups I and II within Safety and Surveillance and comprise of 10 therapeutic area multidisciplinary teams. The Vaccines, Infectious Diseases and Diagnostics team (TAU3) monitors the safety and effectiveness of medicines and medical devices used for the detection, management and prophylaxis of infectious diseases. The team therefore monitors and covers the post-market surveillance and risk assessment of:

Vaccines for the prevention of infectious disease such as influenza, RSV and COVID-19, vaccines for childhood diseases, and travel/occupational vaccines.

Medicines indicated for the treatment of infectious disease such as antibacterials, antifungals, and antivirals., Reporting to the Head of Vaccines, Infectious Diseases and Diagnostics a Benefit Risk Medical Assessor is required to conduct assessment of a wide range of data, contributing to the Agencys wider vigilance activities and ensuring that safe and effective medicines and medical devices continue to be available to UK patients.

Analyse evidence from a range of sources as well as taking into account stakeholders and patients views to monitor the benefit and risk balance of medicinal products and devices in clinical use.

Undertake effective matrix working as appropriate across the Benefit-Risk Evaluation functions, the wider Safety and Surveillance Group and Agency life-cycle Groups.

Ensure that scientific, technical, and clinical benefit-risk assessment of potential safety issues takes place promptly and contributes to sound regulatory decisions regarding safety of medicines and devices.

The Medicines and Healthcare products Regulatory Agency enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.

The Safety and Surveillance Group brings together into a single integrated structure, expertise on the safety of all medical products with enforcement capabilities. These functions are supported by the Agencys data and evidence generating capabilities complementing our signal generating abilities delivered via the common vigilance platform SafetyConnect.

Safety remains at the heart of all our decision making across the product life cycle. The central mission of the Safety & Surveillance portfolio is to protect the public by appropriately identifying, assessing and managing the risks associated with medical products. In every aspect of this work, we harness the best science, technology, information and professional practice to protect patients in new and impactful ways.